Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

758 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.
Robak T, Błasińska-Morawiec M, Błoński J, Hellmann A, Hałaburda K, Konopka L, Kotlarek-Haus S, Potoczek S, Hansz J, Dmoszyńska A, Urasiński I, Zdziarska B, Dwilewicz-Trojaczek J, Hołowiecki J, Skotnicki AB. Robak T, et al. Eur J Haematol. 1999 Jan;62(1):49-56. doi: 10.1111/j.1600-0609.1999.tb01114.x. Eur J Haematol. 1999. PMID: 9918312
2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemia.
Robak T, Błasińska-Morawiec M, Krykowski E, Hansz J, Komarnicki M, Kazimierczak M, Konopka L, Maj S, Hellmann A, Zaucha JM, Urasiński L, Zdziarska B, Kotlarek-Haus S, Usnarska-Zubkiewicz L, Kuratowska Z, Dwilewicz-Trojaczek J, Hołowiecki J, Krawczyk-Kulis M, Grieb P. Robak T, et al. Leuk Lymphoma. 1996 Jun;22(1-2):107-11. doi: 10.3109/10428199609051736. Leuk Lymphoma. 1996. PMID: 8724536 Clinical Trial.
Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia.
Robak T, Błasinka-Morawiec M, Krykowski E, Kasznicki M, Płuzanska A, Potemski P, Hellmann A, Zaucha JM, Lewandowski K, Dmoszynska A, Hansz J, Komarnicki M, Konopka L, Durzynski T, Ceglarek B, Sikorska A, Kotlarek-Haus S, Mazur G, Urasinski I, Zdziarska B, Maj S, Kopec I, Skotnicki AB, Dwilewicz-Trojaczek J, Grieb P, et al. Robak T, et al. Leuk Lymphoma. 1996 Aug;22(5-6):509-14. doi: 10.3109/10428199609054790. Leuk Lymphoma. 1996. PMID: 8882965 Clinical Trial.
Activity of 2-chlorodeoxyadenosine (Cladribine) in 2-hour intravenous infusion in 94 previously treated patients with low grade non-Hodgkin's lymphoma.
Róbak T, Gora-Tybor J, Krykowski E, Walewski JA, Borawska A, Pluźańska A, Potemski P, Hellmann A, Zaucha JM, Konopka L, Ceglarek B, Durźyński T, Sikorska A, Michalak K, Urasiński J, Opalińska J, Dmoszyńska A, Adamczyk-Cioch MB, Kuratowska Z, Dwilewicz-Trojaczek J, Boguradzki P, Deren M, Maj S, Grieb P. Róbak T, et al. Leuk Lymphoma. 1997 Jun;26(1-2):99-105. doi: 10.3109/10428199709109163. Leuk Lymphoma. 1997. PMID: 9250793 Clinical Trial.
2-Chlorodeoxyadenosine (cladribine)-related eosinophilia in patients with lymphoproliferative diseases.
Robak T, Błasińska-Morawiec M, Krykowski E, Hellmann A, Lewandowski K, Dmoszyńska A, Adamczyk-Cioch M, Kazimierczak M, Trepińska E, Dwilewicz-Trojaczek M, Kuratowska Z, Skotnicki AB, Nowak WS, Zdziarska B, Urasiński I. Robak T, et al. Eur J Haematol. 1997 Oct;59(4):216-20. doi: 10.1111/j.1600-0609.1997.tb00980.x. Eur J Haematol. 1997. PMID: 9338619
The effect of 2-h infusion of 2-chlorodeoxyadenosine (cladribine) with prednisone in previously untreated B-cell chronic lymphocytic leukaemia.
Robak T, Błasińska-Morawiec M, Błoński JZ, Krykowski E, Komarnicki M, Trepińska E, Kaźmierczuk M, Hansz J, Dmoszyńska A, Roliński J, Konopka L, Skotnicki AB, Nowak WS, Kotlarek-Haus S, Zdziarska B, Urasiński I. Robak T, et al. Eur J Cancer. 1997 Dec;33(14):2347-51. doi: 10.1016/s0959-8049(97)00349-3. Eur J Cancer. 1997. PMID: 9616280
758 results